Supply Chain

Developing science is good; developing successful commercialization strategies is great.

EFPIA signs joint declaration championing open trade in the EU.

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

Experts discuss the trends, challenges, and possibilities of cryopreservation for cell and gene – and how it can freeze time in manufacturing.

It’s time to go back to basics when it comes to pharmaceutical supply chains and preventing shortages.

Experts from Lonza share how biologics and CGT can recognize the gaps and similarities that can be utilized to optimize cell culture media challenges.

Why some stakeholders are not happy about the FDA’s removal of tirzepatide from the drug shortage list.

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Sitting Down With… Lars Petersen, President and CEO, FUJIFILM Diosynth Biotechnologies

Supply chain lessons have been learned since COVID-19, so why are we seeing so many drug shortages?